Hansa Biopharma AB Tangible Net Worth Ratio
Hansa Biopharma AB tangible net worth ratio. Hansa Biopharma AB (HNSA) has a Tangible Net Worth Ratio of 47.3% as of June 2023. This metric is calculated by deducting intangible assets (Skr95.94 Million) from net assets (Skr182.18 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check Hansa Biopharma AB strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Hansa Biopharma AB (2008–2022)
Tangible net worth ratio of Hansa Biopharma AB from 2008 to 2022. This chart shows how Hansa Biopharma AB's Tangible Net Worth Ratio has changed across 15 annual periods from 2008 to 2022. As of June 2023, the ratio stands at 47.3%, reflecting net assets of Skr182.18 Million with intangible assets of Skr95.94 Million SEK. See HNSA current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Hansa Biopharma AB Tangible Net Worth Ratio by Year (2008–2022)
Hansa Biopharma AB tangible net worth ratio by year from 2008 to 2022. The table below presents the year-by-year Tangible Net Worth Ratio for Hansa Biopharma AB from 2008 to 2022, covering 15 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market value of Hansa Biopharma AB.
| Year | Tangible NW Ratio | Net Assets (SEK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2022 | 92.2% | Skr602.91 Million | Skr46.87 Million | Skr1.69 Billion | ▼ -4.0 pp |
| 2021 | 96.2% | Skr757.57 Million | Skr28.76 Million | Skr1.01 Billion | ▼ -1.3 pp |
| 2020 | 97.5% | Skr1.24 Billion | Skr31.41 Million | Skr1.43 Billion | ▲ +3.4 pp |
| 2019 | 94.1% | Skr562.82 Million | Skr33.35 Million | Skr664.24 Million | ▼ -2.1 pp |
| 2018 | 96.1% | Skr859.88 Million | Skr33.20 Million | Skr944.82 Million | ▲ +1.5 pp |
| 2017 | 94.6% | Skr630.66 Million | Skr33.75 Million | Skr680.41 Million | ▲ +7.5 pp |
| 2016 | 87.1% | Skr283.69 Million | Skr36.55 Million | Skr310.67 Million | ▲ +4.3 pp |
| 2015 | 82.8% | Skr211.53 Million | Skr36.33 Million | Skr224.09 Million | ▲ +56.9 pp |
| 2014 | 25.9% | Skr49.80 Million | Skr36.90 Million | Skr54.31 Million | ▲ +14.4 pp |
| 2013 | 11.5% | Skr45.68 Million | Skr40.42 Million | Skr50.78 Million | ▼ -24.7 pp |
| 2012 | 36.2% | Skr63.24 Million | Skr40.37 Million | Skr65.80 Million | ▼ -60.4 pp |
| 2011 | 96.6% | Skr34.71 Million | Skr1.19 Million | Skr40.90 Million | ▼ -0.6 pp |
| 2010 | 97.2% | Skr32.17 Million | Skr898.50K | Skr37.80 Million | ▼ -2.8 pp |
| 2009 | 100.0% | Skr24.92 Million | Skr0.00 | Skr38.15 Million | ▲ +0.0 pp |
| 2008 | 100.0% | Skr40.73 Million | Skr0.00 | Skr44.87 Million | — |